Post on 13-Nov-2020
ISSN: 0973-4945; CODEN ECJHAO
E-Journal of Chemistry
http://www.e-journals.net 2010, 7(4), 1156-1161
UV Spectrophotometric Determination of
Hydrochlorothiazide and Olmesartan Medoxomil in
Pharmaceutical Formulation
A.T. HEMKE*, M.V. BHURE, K.S. CHOUHAN,
K.R. GUPTA and S.G. WADODKAR
Department of Pharmaceutical Chemistry,
S.K.B. College of Pharmacy New Kamptee, Nagpur, M.S. India.
hemkeat@rediffmail.com
Received 6 November 2009; Accepted 2 January 2010
Abstract: A simple, specific, accurate, precise and reproducible method has been
developed and validated for the simultaneous estimation of hydrochlorothiazide
and olmesartan medoxomil in combined dosage form by UV spectrophotometric
method. UV spectrophotometric method includes simultaneous equation method
(Method I) 271.5 nm and 257.0 nm λmax of both the drugs were selected,
absorbance Ratio method (Method II) 261.5 nm an isoabsorptive wavelength and
257.0 nm were selected for estimation of hydrochlorothiazide and olmesartan
medoxomil respectively and Three wavelength method (Method III), two
wavelengths were selected such that hydrochlorothiazide give same absorbances
(263.8 and 278.4 nm) at two selected wavelength while third wavelength (316.5
nm) was such that olmesartan gives nearly zero absorbance. The two drugs
follow Beer’s law over the concentration range of 5-25 µg/mL. The % recoveries
of the both the drugs were found to be nearly 100 % representing the accuracy of
the proposed methods. Validation of the proposed methods was carried out for its
accuracy, precision, specificity and ruggedness according to ICH guidelines. The
proposed methods can be successfully applied in routine work for the
determination of hydrochlorothiazide and olmesartan medoximil in combined
dosage form.
Keywords: Hydrochlorothiazide, Olmesartan medoxomil, UV spectroscopy, Simultaneous Equation
method, Absorbance Ratio method.
Introduction
Hydrochlorothiazide (HTZ) is a drug used in the treatment of hypertension. It blocks the
reabsorption of Na+ in the distal convoluted tubules by inhibiting the luminal membrane
1157 A.T. HEMKE et al.
bound Na+/Cl
- co-transport system. HTZ
1, chemically
it is 6-chloro-3,4-dihydro-2H-1,2,4-
benzothiadiazine-7-sulphonamide1, 1 dioxide. Olmesartan medoxomil (OLM) is used in the
treatment of hypertension. It is angiotensin II receptor antagonists. OLM2, chemically it is
2,3-dihydroxy- 2-butenyl -4- (1-hydroxy-1-methylethyl)- 2-propyl-1- [p-(o-1H-tetrazol-5-yl-
phenyl) benzyl] imidazole-5-corboxylate, cyclic 2,3-corbonate. Literature survey revealed
that the methods reported earlier were only for the analysis of single drug like UV-
spectrophotometry3 for HTZ and LC
4, UV
5 and Capillary electrophoresis
6 for determination
of OLM. In combination methods are reported for HTZ with telmisartan7 irbesartan
8,
valsartan9 and lisinopril
10 while OLM with ramipril
11 for their determinations in
pharmaceutical formulation. HPTLC12
method is reported for the HTZ with OLM
combination. The paper presents two simple, accurate, reproducible, rapid and economical
methods for simultaneous analysis of the two components in tablet formulation.
Experimental
SHIMADZU double beam UV visible spectrophotometer (model 1700) with 1 cm matched
quartz cuvettes were used for all absorbance measurements. Shimadzu AUX 220 balance
was used for weighing the samples. All the chemicals used were of AR grade. Double
distilled water and Whatman filter paper (no.41) were used throughout the experimental
work.
Multicomponent tablet olmetor-H (HTZ 12.5 mg and OLM 20.0 mg) manufactured by
Hetero drugs ltd, Dist- Baddi, Himachal Pradesh. All chemicals and reagents used were of
analytical grade.
Standard stock solution
Standard stock solutions of HTZ and OLM were prepared individually in methanol having
concentration of 100 µg/mL and 160 µg/mL respectively. Aliquot portions of the stock
solutions were diluted individually with distilled water to get final concentration of 10
µg/mL and 16 µg/mL for HTZ and OLM respectively. These working standard solutions
were scanned in the range of 400-200 nm in 1.0 cm cell against solvent blank.
Determination of absorptivity value
The solutions of each drug in tripilicate were read against solvent blank at the selected
wavelengths and A(1% 1 cm) value were calculated using below formula:
Absorbance at selected wavelengths Absorptivity, A (1% 1 cm) =
Concentration in g / 100 mL
Study of linearity
Stock solutions each of HTZ and OLM having concentration of 100 µg/mL were prepared.
Aliquots of each solution were appropriately diluted and the final dilutions were read at the
selected wavelengths individually and in their combination. The correlation coefficient was
found to be less than 1. The method was first applied to standard laboratory mixture which
yielded encouraging results and the proposed methods were applied to marketed
formulation.
Assay
Twenty tablets were weighed and average weight was calculated. The tablets were triturated
thoroughly and mixed. Tablet powder equivalent to 12.5 mg of hydrochlorothiazide (~20.0
mg of olmesartan medoximil, on the basis of label claim) was transferred to 50.0 mL
UV-Spectrophotometric Determination of Hydrochlorothiazide 1158
volumetric flask, dissolved by sonication for 15 min. with sufficient quantity of methanol
and volume was made up to mark with methanol. The content was filtered through Whatman
filter paper (no.41). A 10.0 mL portion of the above filtrate was further diluted to 50.0 mL
with distilled water. A 10.0 mL portion of this solution was further diluted to 50.0 mL with
distilled water.
The final dilution of all sample solutions were read at the selected wavelengths using
blank methanol with distilled water. The amount of each drug was estimated by proposed
methods using the following formulae:
Simultaneous equation method (Method I)
C HTZ = A2ay1 – A1ay2 / ax2ay1 – ax1ay2
C OLM = A1ax2 – A2ax1 / ax2ay1 – ax1ay2
where:
ax1= The absorptivity of HTZ at 257.0 nm, ax2= The absorptivity of HTZ at 271.5 nm
ay1= The absorptivity of OLM at 257.0 nm, ay2= The absorptivity of OLM at 271.5 nm
A1 and A2 are the absorbances of the diluted sample at 257.0 and 271.5 nm respectively
Table 1. Results of estimation in marketed formulation.
Label Claim % Label Claim
Method I Method II Method III
HTZ OLM HTZ OLM HTZ OLM HTZ OLM
101.2 99.8 101.7 99.8 100.5 98.1
99.8 102.0 100.0 101.9 100.9 98.6
100.9 100.0 101.6 100.2 99.0 98.2
101.2 100.4 101.2 100.1 101.0 99.0
12.5 20.0
101.6 101.2 102.1 100.1 101.8 98.7
Mean 100.94 100.68 101.32 100.66 100.64 98.52
S.D. (±) 0.61 0.82 0.70 0.82 1.03 0.37
% R.S.D
0.60 0.81 0.69 0.81 1.02 0.38
Method I- Simultaneous equation method, Method-II- Absorbance ratio method, Method III- Three
wavelength method.
Absorbance ratio method (Method II)
vxv
vmOLNE
xvx
vmHTZ
a
Ax
QQC
a
Ax
QQC
−
−=
−
−=
Where:
Q m = Absorbance ratio of sample mixture at 257.0/261.5 nm Q x = Ratio of absorptivity of OLM at 257.0/261.5 nm
Q y = Ratio of absorptivity of HTZ at 257.0/261.5 nm
ax = Absorptivity of HTZ at 257.0, ay = Absorptivity of OLM at 261.5
A = Absorbance of sample mixture at isobestic wavelength (261.5 nm)
Three wavelength method (Method III)
( ) xCsAs
AuCuCOLME =,
Cu = Concentration of unknown, Cs = Concentration of standard
As = (A1-A2), were A1 = Absorbance of standard OLM at 263.8 nm
A2 = Absorbance of standard OLM at 278.4 nm
1159 A.T. HEMKE et al.
Au = (A1-A2), were A1 = Absorbance of sample OLM at 263.8 nm
A2 = Absorbance of sample OLM at 278.4 nm
( ) xCsAs
AuCuCHCTZ =,
Cu = Concentration of unknown, Cs = Concentration of standard
As = Abs. Of standard at 316.5 nm, Au = Abs. of unknown at 316.5 nm
The results are shown in Table 1 for all proposed methods.
Method validation
Validation of the proposed methods was carried out for its accuracy, precision, specificity
and ruggedness according to ICH guidelines.
Accuracy Recovery studies were carried out at four different levels by adding the pure drug to previously
analysed tablet powder sample. From the amount of drug total drug found, percentage recovery
was calculated by proposed three methods and results are shown in Table 2a and 2b.
Table 2a. Results of recovery studies.
Amount of pure drug recovered, mg % Recovery Amount of pure
drug added, mg Method I Method II Method I Method II
HTZ OLM HTZ OLM HTZ OLM HTZ OLM HTZ OLM
2.6 3.9 2.62 3.91 2.68 3.89 100.7 100.2 103.0 99.7
5.0 7.4 5.1 7.32 5.10 7.30 102.0 98.9 102.0 98.7
7.3 11.6 7.39 11.51 7.39 11.43 101.3 99.2 101.3 98.5
10.0 15.7 9.95 15.59 9.95 15.40 99.5 99.3 100.0 98.1
Mean 100.87 99.4 101.57 98.75
± S.D 0.92 0.48 1.09 0.59
% R.S.D (CV) 0.91 0.49 1.07 0.56
Table 2b. Results of recovery studies.
Amount of pure drug
recovered, mg % Recovery Amount of pure
drug added, mg Method III Method III
HTZ OLM HTZ OLM HTZ OLM
2.4 3.7 2.43 3.69 101.2 100.0
4.8 7.2 4.82 7.10 100.4 98.6
7.2 11.1 7.27 10.89 100.9 98.1
9.0 14.0 8.98 13.89 99.8 99.2
Mean 101.57 98.75
± S.D 1.09 0.59
% R.S.D (CV) 1.07 0.56
Method I- Simultaneous equation method, Method-II- Absorbance ratio method, Method III- Three
wavelength method.
Precision
Inter-day precision
It was done by analysing the solutions by same analyst on alternate days till 5th
day. The
% RSD is shown in Table 3. Results indicate that the solution is stable up to 1day, thereafter
degradation may have taken place leading lower percent label claim.
UV-Spectrophotometric Determination of Hydrochlorothiazide 1160
Intra day precision
It was done by analysing the solutions by same analyst within a day. The % RSD is shown
in Table 3. Results indicate that the solution is stable up to 4 h and thereafter, degradation
may have taken place in the solution.
Table 3. Results of ruggedness studies.
Mean percent of label claim ±%R.S.D
Method I Method II Method III Parameter
HTZ OLM HTZ OLM HTZ OLM
Precision
Intra-day
(n=3) 97.63±0.80 97.10±1.02 96.00±0.88 97.13±0.83 97.10±1.99 96.43±5.36
Inter-day
(n=3) 87.66±10.41 92.63±7.42 81.53±17.38 95.36±5.15 87.36±14.31 101.40±1.78
Analyst-
Analyst 101.40±0.12 99.33±0.66 101.0 ±0.81 99.23 ±0.88 100.16±0.76 100.86±2.70
Method I- Simultaneous equation method, Method-II- Absorbance ratio method, Method III- Three
wavelength method.
Linearity and range
Accurately weighed quantities of tablet powder equivalent to 80, 90, 100, 110 and 120% of
label claim of HTZ were taken in a series of 50 mL volumetric flasks and dilutions were
made as under sample solution. The graphs of % label claim vs. absorbance were plotted for
Method I and II were plotted, were found to be linear.
Ruggedness
It was done by analysing the samples solutions by three different analysts. The % RSD by
proposed methods is shown in Table 3 and was found to be within limits.
Stability
Sample solution: Accurately weighed quantities of tablet content equivalent to about 12.5
mg HCTZ, were transferred to 50.0 mL volumetric flask. These entire samples were stored
for 24 h under following different conditions.
At 50 0C after addition of 1.0 mL of 1N HCl (Acid)
At 50 0C after addition of 1.0 mL of 1N NaOH (Alkali)
At 50 0C after addition of 1.0 mL of 6% H2O2 (Oxide)
At 60 0C (Heat)
After the specified period, the results were analysed by proposed methods and results
are shown in Table 4.
Table 4. Results of stability studies.
Percent of un-degraded drug
Method I Method II Method III Sample
HTZ OLM HTZ OLM HTZ OLM
1N HCl 75.5 69.19 63.0 73.3 75.3 78.0
1N NaOH ---- ---- ---- ---- ---- ----
6% H2O2 69.7 102.4 80.3 98.7 78.1 91.3
60 0C 97.3 95.9 97.3 95.9 100.3 94.3
Method I- Simultaneous equation method, Method-II- Absorbance ratio method, Method III- Three
wavelength method.
1161 A.T. HEMKE et al.
Results and Discussion
The study of spectrum recorded (Figure 1) showed that the HTZ exhibited two λmax at 271.6 and 316.5 nm while OLM showed at 257.0 nm. Simultaneous Equation was constructed using 271.5 nm and 257.0 nm λmax of both the drugs, Absorbance Ratio method utilises 261.5 nm an isoabsorptive wavelength and 257.0 nm for estimation of hydrochlorothiazide and Olmesartan medoxomil respectively and Three-wavelength method, two wavelengths were selected such that hydrochlorthiazide give same absorbance (263.8 and 278.4 nm) at two selected wavelength while third wavelength (316.5 nm) was such that olmesartan gives nearly zero absorbance. The difference in absorbance of olmesartan at the former two selected wavelength was used for estimation of OLM while at latter wavelength HCTZ was estimated. The two drugs follow Beer’s law over the concentration range of 5-25 µg/mL. The values of relative standard deviation were found satisfactory and the recovery studies were close to 100%. The stability studies showed that the drugs are susceptible to stress condition that indicates, the drugs are not intrinsically stable towards such conditions.
Figure 1. Overlain spectrum of hydrochlorothiazide and olmesartan medoxomil.
Conclusion
The proposed methods were found to be accurate, simple, rapid and reproducible. Thus all the methods can be applied in the routine analysis of the hydrochlorothiazide and Olmesartan medoxomil in formulations.
Acknowledgments
The authors are thankful to Alembic Pharmaceutical Ltd. for providing standard drug samples and also to S.K.B.College of Pharmacy, Kamptee for providing the facilities to carry out the work.
References
1. “Indian Pharmacopoeia”; Vol. II Govt. of India, Ministry of Health and Family Welfare, Published by controller of publication New Delhi, 1996, 371.
2. Adele M and Neil J O, Ed., The Merck Index 13th
Edn, published by Merck research lab, division of Merck & Co, White house station, NJ, USA, 2001, 6909.
3. Sachin A, Jain D K and Trivedi P, Indian Drugs, 1997, 34: 168-171. 4. Liu D, Hu P, Matsushima N, Li X, Li L and Jiang J, J Chromatogr B Analyt Technol
Biomed Life Sci., 2007, (1-2), 190-197. 5. Celebier M and Altinos S, Pharmazie, 2007, 62, 419-22 6. Mustafa C and Sacide A J, Chromatgraphia, 2007, 66, 127 7. Wankhede S B, Tajne M R, Gupta K R and Wadodkar S G, Indian J Pharm Sci.,
2007, 69, 298-300. 8. Vetuschi C, Giannandrea A, Carlucci G and Mazzeo P, Farmaco, 2005, 60, 665-670. 9. Kadam B R and Bari S B, Acta Chromatographia, 2007, 18, 67.
10. Ivanovic D, Medenica M, Malenovic A and Jancic B, Accredit Qual Assur., 2004, 9, 76-81.
11. Chintan V P, Amit P K, Anandi D C and Kalpesh T P, Eur J Anal Chem., 2007, 2, 57.
12. Shah N J, Suhagia B N, Shah R R and Patel N M, Indian J Pharm Sci., 2007, 69, 834-836.
Olmesartan Medoximil
Hydrochlorothiazid
Submit your manuscripts athttp://www.hindawi.com
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Inorganic ChemistryInternational Journal of
Hindawi Publishing Corporation http://www.hindawi.com Volume 2014
International Journal ofPhotoenergy
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Carbohydrate Chemistry
International Journal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Journal of
Chemistry
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Advances in
Physical Chemistry
Hindawi Publishing Corporationhttp://www.hindawi.com
Analytical Methods in Chemistry
Journal of
Volume 2014
Bioinorganic Chemistry and ApplicationsHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
SpectroscopyInternational Journal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014
Medicinal ChemistryInternational Journal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Chromatography Research International
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Applied ChemistryJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Theoretical ChemistryJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Journal of
Spectroscopy
Analytical ChemistryInternational Journal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Journal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Quantum Chemistry
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Organic Chemistry International
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
CatalystsJournal of
ElectrochemistryInternational Journal of
Hindawi Publishing Corporation http://www.hindawi.com Volume 2014